Matt Hancock giving Downing Street coronavirus press briefing

Matt Hancock giving Downing Street coronavirus press briefing

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video announces the rollout of free flu jabs for those over 50 in England starting December 1st, emphasizing the importance of vaccination to prevent the dangerous combination of flu and COVID-19. It highlights the UK's significant contribution to the global search for a COVID-19 vaccine, with promising results from trials by Moderna, Pfizer, and AstraZeneca. The Pfizer vaccine has shown 95% efficacy and is seeking emergency use authorization from the FDA.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is it particularly important to get a flu jab this winter?

To prevent the dangerous combination of flu and COVID-19.

Because flu vaccines are free for everyone.

Because it is mandatory for all citizens.

To support local pharmacies.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What role has the UK played in the global search for a COVID-19 vaccine?

The UK has not been involved in the vaccine search.

The UK has provided more international support than any other country.

The UK has only focused on domestic vaccine development.

The UK has discouraged international collaboration.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which vaccine candidates have shown promising results in recent trials?

Johnson & Johnson, Moderna, and Astra Zeneca

Moderna, Pfizer Biontech, and Astra Zeneca Oxford

Pfizer Biontech, Sinovac, and Sputnik V

Astra Zeneca, Sinopharm, and Moderna

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What did Pfizer Biontech recently announce regarding their COVID-19 vaccine?

They have found the vaccine to be ineffective.

They have halted all vaccine trials.

They have submitted for emergency use authorization.

They have decided not to release the vaccine.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the reported efficacy of the Pfizer Biontech vaccine based on phase three data?

85%

90%

100%

95%